Sarepta Therapeutics to Present Company Overview at the Credit Suisse 25th Annual Healthcare
Conference
Webcast Accessible via Sarepta Therapeutics Website
Sarepta Therapeutics (NASDAQ:SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, announced today
that it is scheduled to present at the Credit Suisse 25th Annual Healthcare Conference in Phoenix, Arizona on
Monday, November 7, 2016 at 5:30 PM, Eastern Time. Edward Kaye, Sarepta's chief executive officer, will be the
presenter at the fireside chat.
The presentation will be webcast live on the investor relations section of the Sarepta Therapeutics website
at www.sarepta.com and will be archived under the events and presentations section following the presentation
for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for
any software download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of unique
RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing
the development of its potentially disease-modifying DMD drug candidates. For more information, please visit us at www.sarepta.com.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website
at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for
important information about us.
Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052
iestepan@sarepta.com
or
W2O Group
Brian Reid, 212-257-6725
breid@w2ogroup.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005220/en/